Evidence map›Paper›PMID 24366538›Full record

ArticleInternational journal of oncology2014

GLI1 upregulates C-JUN through a specific 130-kDa isoform.

Lauren Amable, Elaine Gavin, Kenji Kudo, Erhong Meng, Rodney P Rocconi, Lalita A Shevde, Eddie Reed

Open access · hybridAbstract read
In one paragraph

Article in International journal of oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Lauren AmableNational Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD 20892, USA.
Elaine GavinMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Kenji KudoMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Erhong MengMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Rodney P RocconiMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Lalita A ShevdeDepartment of Pathology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Eddie ReedNational Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD 20892, USA.
National Institute on Minority Health and Health Disparities · USUniversity of South Alabama · USUSA Mitchell Cancer Institute · USUniversity of Alabama at Birmingham · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

The Hedgehog pathway is molecularly linked to increased resistance to cisplatin and increased repair of platinum-DNA damage, through C-JUN. GLI1, which has five known isoforms, is a positive transcriptional regulator in Hedgehog. Southwestern blot assay, EMSA and ChIP assays indicate that only one of five isoforms of GLI1 may be responsible for the Hedgehog link with C-JUN and thus, increased platinum-DNA adduct repair. Cancer tissues express this 130-kDa isoform at levels 6-fold higher than non-malignant tissues; and this isoform exists in abundance in six of seven ovarian cancer cell lines examined.

Indexed as

CisplatinDNA DamageDrug Resistance, NeoplasmFemaleHedgehog ProteinsHumansJNK Mitogen-Activated Protein KinasesOvarian NeoplasmsProtein IsoformsTranscription FactorsTumor Cells, CulturedZinc Finger Protein GLI1CisplatinGLI1 protein, humanHedgehog ProteinsJNK Mitogen-Activated Protein KinasesProtein IsoformsTranscription FactorsZinc Finger Protein GLI1

Identifiers

PMID24366538
PMCPMC3928471
OpenAlexW2083207421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.